Omega-3脂肪酸作为年龄相关性黄斑变性的保护因素:前瞻性队列与孟德尔随机化分析
该研究基于英国生物银行258350名无年龄相关性黄斑变性(AMD)的欧洲裔人群进行前瞻性队列分析,并利用全基因组关联研究数据进行两样本孟德尔随机化分析。结果显示血浆omega-3和DHA水平较高与AMD风险降低相关,孟德尔随机化分析提示遗传决定的较高omega-3水平可降低干性、湿性及任何AMD风险。
要点
- 血浆omega-3较高与AMD风险降低相关(HR 0.80,95%CI 0.72-0.95,P=0.006)。
- 遗传决定的较高omega-3水平与干性AMD风险降低相关(OR 0.83,95%CI 0.73-0.96,P=0.010)。
- omega-3与DHA水平和AMD遗传风险之间无显著交互作用(所有P>0.05)。
核心结论
- 前瞻性队列和孟德尔随机化分析均提示omega-3和DHA可能对AMD具有保护作用,支持需要进一步临床试验来验证其在AMD预防和治疗中的效果。
研究设计与样本
- 前瞻性队列研究纳入英国生物银行258350名无AMD的欧洲裔个体。
- 两样本孟德尔随机化分析使用血浆omega-3和DHA的全基因组关联研究数据(英国生物银行,n=115006)及AMD数据(干性、湿性及任何AMD;FinnGen,n=208690-209122)。
- 队列分析采用Cox回归评估血浆omega-3和DHA水平与AMD发病的关联,并校正全身性协变量和AMD多基因风险评分。
- 孟德尔随机化主要模型为随机效应逆方差加权模型,另采用5种敏感性模型。
主要发现
- 中位随访12.9年期间,5068人(1.9%)发生AMD。
- 血浆omega-3水平较高(毫摩尔/升)与接受AMD诊断风险降低相关(HR 0.80,95%CI 0.72-0.95,P=0.006)。
- 血浆DHA水平较高(毫摩尔/升)与接受AMD诊断风险降低相关(HR 0.65,95%CI 0.44-0.96,P=0.029)。
- 遗传决定的较高血浆omega-3水平降低干性AMD风险(OR 0.83,95%CI 0.73-0.96,P=0.010)、湿性AMD风险(OR 0.76,95%CI 0.65-0.88,P<0.001)及任何AMD风险(OR 0.82,95%CI 0.74-0.92,P<0.001)。
- 遗传决定的较高血浆DHA水平与湿性AMD风险降低相关(OR 0.79,95%CI 0.65-0.96,P=0.017)及任何AMD风险降低相关(OR 0.84,95%CI 0.72-0.98,P=0.030)。
关键数值与推荐
- 孟德尔随机化分析中,主要模型P<0.05且至少2种敏感性模型P<0.05时认为因果关联显著。
- omega-3和DHA水平与AMD遗传风险(多基因风险评分、补体因子H和年龄相关性黄斑病变易感基因2基因型)之间无显著交互作用(所有P>0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Epidemiologic studies and clinical trials have reported inconsistent findings regarding omega-3 fatty acids' protective role in age-related macular degeneration (AMD). We investigated their association in a prospective cohort and examined causality using Mendelian randomization (MR) analyses. DESIGN: Prospective cohort study and 2-sample MR analyses. PARTICIPANTS: The cohort included 258 350 AMD-free individuals of European descent from the UK Biobank. Mendelian randomization analyses used genome-wide association study data on plasma omega-3 and docosahexaenoic acid (DHA) (UK Biobank, n = 115 006) and AMD (dry, wet, and any; FinnGen, n = 208 690-209 122). METHODS: Cox regression assessed the association between plasma omega-3 and DHA levels and AMD incidence, adjusting for systemic covariates and AMD polygenetic risk score (PRS). Interaction effects of AMD genetic risk (PRS, complement factor H and age-related maculopathy susceptibility 2 genotypes), and plasma omega-3 and DHA levels were tested. For MR analyses, we used random-effect inverse-variance weighted model as primary, with 5 sensitivity models. Causality was considered significant if P < 0.05 in the primary model and at least 2 sensitivity models. MAIN OUTCOME MEASURES: Risk of AMD. RESULTS: Over 12.9 years, 5068 people (1.9%) demonstrated AMD. Higher plasma levels (in millimoles per liter) of omega-3 (hazard ratio [HR], 0.80; 95% confidence interval [CI], 0.72-0.95; P = 0.006) and DHA (HR, 0.65; 95% CI, 0.44-0.96; P = 0.029) were associated with lower risk of receiving an AMD diagnosis. Mendelian randomization showed genetic predisposition to higher plasma omega-3 levels reduced the risk of dry AMD (odds ratio [OR], 0.83; 95% CI, 0.73-0.96; P = 0.010), wet AMD (OR, 0.76; 95% CI, 0.65-0.88; P < 0.001), and any AMD (OR, 0.82; 95% CI, 0.74-0.92; P < 0.001). Similar results were found for plasma DHA levels (wet AMD:OR, 0.79; 95% CI, 0.65-0.96; P = 0.017; any AMD: OR, 0.84; 95% CI, 0.72-0.98; P = 0.030). No significant interaction was found between omega-3 and DHA levels and AMD genetic risk (all P > 0.05). CONCLUSIONS: Both the prospective and MR analyses suggest omega-3 and DHA may protect against AMD, supporting the need for further clinical trials to test their effectiveness in AMD prevention and treatment. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
引用
- Xue CC, Li H, Yu M, et al. Omega-3 Fatty Acids as Protective Factors for Age-Related Macular Degeneration: Prospective Cohort and Mendelian Randomization Analyses. Ophthalmology. 2024. PMID: 39662686. doi:10.1016/j.ophtha.2024.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。